Status:
WITHDRAWN
Chest Computed Tomography (CT) Screening Study With Antibody Testing
Lead Sponsor:
Mayo Clinic
Conditions:
Lung Cancer
Eligibility:
All Genders
50-75 years
Brief Summary
The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.
Detailed Description
EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic outcomes.
Eligibility Criteria
Inclusion
- Persons 50-75
- Asymptomatic for lung cancer
- Current or former (stopped smoking less than 10 years ago) cigarette smokers
- History of cigarette smoking of at least 20 pack years
- History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years).
- Mentally competent individuals to sign an informed consent.
- Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy.
- A fully informed signed consent form must have been obtained.
Exclusion
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01203579
Start Date
September 1 2011
End Date
September 1 2011
Last Update
June 21 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905